Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)

SHE:002262 Revenue

Jiangsu Nhwa Pharmaceutical Co., LTD had revenue of 1.46B CNY in the quarter ending September 30, 2025, with 5.70% growth. This brings the company's revenue in the last twelve months to 6.02B, up 8.90% year-over-year. In the year 2024, Jiangsu Nhwa Pharmaceutical Co., LTD had annual revenue of 5.70B with 13.01% growth.

• Revenue (ttm): 6.02B
• Revenue Growth: +8.90%
• P/S Ratio: 4.00
• Revenue / Employee: 1.02M
• Employees: 5,923
• Market Cap: 24.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.70B	656.13M	13.01%
Dec 31, 2023	5.04B	742.99M	17.28%
Jan 1, 2023	4.30B	362.85M	9.22%
Jan 1, 2022	3.94B	574.36M	17.09%
Dec 31, 2020	3.36B	-788.01M	-18.99%